Benitec Biopharma Inc (BNTC)
8.95
+0.08
(+0.92%)
USD |
NASDAQ |
May 03, 16:00
8.99
+0.04
(+0.45%)
After-Hours: 20:00
Benitec Biopharma Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.00 |
December 31, 2020 | 0.00 |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 | |
December 31, 2019 |
Date | Value |
---|---|
September 30, 2019 | |
June 30, 2018 | 0.00 |
March 31, 2018 | 0.00 |
December 31, 2017 | 0.00 |
September 30, 2017 | 0.00 |
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.00 |
December 31, 2015 | 0.00 |
September 30, 2015 | |
June 30, 2015 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2020
--
Maximum
Jun 2020
--
Average
--
Median
Jun 2020
Debt to Equity Ratio Benchmarks
Galectin Therapeutics Inc | -- |
TG Therapeutics Inc | 0.00 |
BioVie Inc | -- |
Jaguar Health Inc | 7.228 |
First Wave BioPharma Inc | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 21.35M |
Total Liabilities (Quarterly) | 5.883M |
Shareholders Equity (Quarterly) | 15.47M |